We've found
10,842 Neurology
clinical trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Non-invasive Measurement of Cerebral Dynamic Autoregulation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis (MS) Clinical Trial
Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis (MS) Clinical Trial
Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis (MS) Clinical Trial
Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
Status: Enrolling,
Phase
III
Updated: 8/11/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Markers of Atrial Fibrillation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Impact of Tecfidera on Gut Microbiota
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder Clinical Trial
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder Clinical Trial
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder Clinical Trial
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder Clinical Trial
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder Clinical Trial
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Natural History of Rett Syndrome & Related Disorders
Status: Enrolling,
Phase
Updated: 4/3/2018
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Natural History of Rett Syndrome & Related Disorders
Status: Enrolling,
Phase
Updated: 4/3/2018
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Natural History of Rett Syndrome & Related Disorders
Status: Enrolling,
Phase
Updated: 4/3/2018
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Natural History of Rett Syndrome & Related Disorders
Status: Enrolling,
Phase
Updated: 4/3/2018
Click here to add this to my saved trials
Epilepsy Clinical Trial
Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Intraventricular Hemorrhage Clinical Trial
VentFirst: A Multicenter RCT of Assisted Ventilation During Delayed Cord Clamping for Extremely Preterm Infants
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Intraventricular Hemorrhage Clinical Trial
VentFirst: A Multicenter RCT of Assisted Ventilation During Delayed Cord Clamping for Extremely Preterm Infants
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Intraventricular Hemorrhage Clinical Trial
VentFirst: A Multicenter RCT of Assisted Ventilation During Delayed Cord Clamping for Extremely Preterm Infants
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Apathy in Tourette Syndrome and Changes in Quality of Life
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Epilepsy Clinical Trial
Navigation and Free Recall in Chronically Implanted Humans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Durvalumab in Pediatric and Adolescent Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Exercise in Adults With Mild Memory Problems
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
10,842 Neurology
clinical trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
Non-invasive Measurement of Cerebral Dynamic Autoregulation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis (MS) Clinical Trial
Updated: 12/31/1969
Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis (MS) Clinical Trial
Updated: 12/31/1969
Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis (MS) Clinical Trial
Updated: 12/31/1969
Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 8/11/2016
A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
Status: Enrolling,
Phase
III
Updated: 8/11/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Updated: 12/31/1969
Markers of Atrial Fibrillation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 4/7/2016
Impact of Tecfidera on Gut Microbiota
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder Clinical Trial
Updated: 12/31/1969
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder Clinical Trial
Updated: 12/31/1969
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder Clinical Trial
Updated: 12/31/1969
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder Clinical Trial
Updated: 12/31/1969
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder Clinical Trial
Updated: 12/31/1969
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 4/3/2018
Natural History of Rett Syndrome & Related Disorders
Status: Enrolling,
Phase
Updated: 4/3/2018
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 4/3/2018
Natural History of Rett Syndrome & Related Disorders
Status: Enrolling,
Phase
Updated: 4/3/2018
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 4/3/2018
Natural History of Rett Syndrome & Related Disorders
Status: Enrolling,
Phase
Updated: 4/3/2018
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 4/3/2018
Natural History of Rett Syndrome & Related Disorders
Status: Enrolling,
Phase
Updated: 4/3/2018
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Intraventricular Hemorrhage Clinical Trial
Updated: 12/31/1969
VentFirst: A Multicenter RCT of Assisted Ventilation During Delayed Cord Clamping for Extremely Preterm Infants
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Intraventricular Hemorrhage Clinical Trial
Updated: 12/31/1969
VentFirst: A Multicenter RCT of Assisted Ventilation During Delayed Cord Clamping for Extremely Preterm Infants
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Intraventricular Hemorrhage Clinical Trial
Updated: 12/31/1969
VentFirst: A Multicenter RCT of Assisted Ventilation During Delayed Cord Clamping for Extremely Preterm Infants
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 11/21/2016
Apathy in Tourette Syndrome and Changes in Quality of Life
Status: Enrolling
Updated: 11/21/2016
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Navigation and Free Recall in Chronically Implanted Humans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab in Pediatric and Adolescent Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 5/8/2017
Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 5/8/2017
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
Updated: 4/25/2018
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
Updated: 4/25/2018
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
Updated: 4/25/2018
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
Updated: 4/25/2018
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Duchenne Muscular Dystrophy (DMD) Clinical Trial
Updated: 4/25/2018
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Status: Enrolling,
Phase
III
Updated: 4/25/2018
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Exercise in Adults With Mild Memory Problems
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials